LENZ Therapeutics, Inc. (LENZ)
NASDAQ·Healthcare·Biotechnology
$9.29
-4.82%
Mkt Cap $294.10M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 24, 2026 | $3.08M | $1.59M | -48.50% | -$0.91 | -$1.16 | -27.47% | — | — |
| Q4 2025 Nov 5, 2025 | $3.05M | $12.50M | +309.95% | -$0.67 | -$0.59 | +11.94% | — | — |
| Q3 2025 Jul 30, 2025 | $714.29K | $5.00M | +600.00% | -$0.58 | -$0.53 | +8.62% | — | — |
| Q2 2025 May 7, 2025 | — | — | — | -$0.55 | -$0.53 | +3.64% | — | — |
| Q1 2025 Mar 19, 2025 | — | — | — | -$0.42 | -$0.46 | -9.52% | — | — |
| Q4 2024 Nov 6, 2024 | — | — | — | -$0.47 | -$0.38 | +19.15% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.49 | -$0.40 | +18.37% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$0.84 | -$3.53 | -320.24% | — | — |
| Q1 2024 Feb 27, 2024 | — | — | — | -$0.13 | -$0.40 | -207.69% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.25 | -$0.19 | +24.00% | — | — |
| Q2 2023 Jun 29, 2023 | — | — | — | -$6.79 | -$6.82 | -0.49% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$2.41 | -$3.00 | -24.54% | — | — |
| Q4 2022 Dec 30, 2022 | — | — | — | -$3.45 | -$3.09 | +10.54% | — | — |
| Q3 2022 Sep 29, 2022 | — | — | — | -$3.11 | -$3.13 | -0.63% | — | — |
| Q2 2022 Jun 29, 2022 | — | — | — | -$3.44 | -$3.42 | +0.57% | — | — |
| Q1 2022 Mar 30, 2022 | — | — | — | — | -$3.39 | — | — | — |
| Q4 2021 Dec 30, 2021 | — | — | — | -$2.73 | -$2.28 | +16.33% | — | — |
| Q3 2021 Sep 29, 2021 | — | — | — | — | -$1.76 | — | — | — |
| Q2 2021 Jun 29, 2021 | — | — | — | — | -$2.19 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$2.38 | — | — | — |